<qa>  What is the name of the day that the subject will continue with their scheduled follow up?Stopping Rules. Adverse reactions, including local-toxicity adverse reactions, or SAEs will lead to immediate return to the SNGH ED for assessment and removal of the TheraGauzetobramycin wound packing. The investigator will assess the need for treatment of the adverse reaction or SAE and, if necessary, either treat or refer for treatment, as appropriate. The subject will continue with their scheduled follow up: Day 3 visit in the ED, Day 6 phone follow up, and Day7 visit in the EVMS Clinical Research Unit. 